Quantum BioPharma Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Public

  • Employees
  • 7

Employees

  • Stock Symbol
  • QNTM

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $1.28
  • (As of Friday Closing)

Quantum BioPharma General Information

Description

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.

Contact Information

Formerly Known As
Century Financial Capital Group, FSD Pharma
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 1 Adelaide Street East
  • Suite 801
  • Toronto, Ontario M5C 2V9
  • Canada
+1 (833)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 1 Adelaide Street East
  • Suite 801
  • Toronto, Ontario M5C 2V9
  • Canada
+1 (833)

Quantum BioPharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quantum BioPharma Stock Performance

As of 20-Nov-2026, Quantum BioPharma’s stock price is $1.28. Its current market cap is $11.1M with 8.59M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.28 $1.42 $1.26 - $12.42 $11.1M 8.59M 149K -$3.19

Quantum BioPharma Financials Summary

As of 30-Sep-2026, Quantum BioPharma has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 24,366 29,790 (222) 31,604
Revenue 0 0 0 0
EBITDA (20,045) (26,029) (14,950) (16,510)
Net Income (20,137) (26,175) (14,203) (17,902)
Total Assets 17,331 11,161 17,119 17,475
Total Debt 924 1,876 825 339
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Quantum BioPharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Quantum BioPharma‘s full profile, request access.

Request a free trial

Quantum BioPharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech s
Drug Discovery
Toronto, Canada
7 As of 2025

Toronto, Canada
 

Orleans, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quantum BioPharma Competitors (2)

One of Quantum BioPharma’s 2 competitors is Avicanna, a Formerly VC-backed company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Avicanna Formerly VC-backed Toronto, Canada
Tetra Bio-Pharma Corporation Orleans, Canada
You’re viewing 2 of 2 competitors. Get the full list »

Quantum BioPharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quantum BioPharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Quantum BioPharma‘s full profile, request access.

Request a free trial

Quantum BioPharma Investments & Acquisitions (7)

Quantum BioPharma’s most recent deal was a Corporate with Unbuzzd Wellness for . The deal was made on 09-Aug-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Unbuzzd Wellness 09-Aug-2024 Corporate Other Consumer Non-Durables
Lucid Psycheceuticals 21-Sep-2021 Merger/Acquisition Drug Discovery
Prismic Pharmaceuticals 28-Jun-2019 Merger/Acquisition Drug Discovery
FSD Jamaica 13-Sep-2018 Joint Venture Other Pharmaceuticals and Biotechnology
Cannara Biotech 19-Jul-2018 Corporate Cultivation
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Quantum BioPharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Quantum BioPharma’s complete esg history, request access »

Quantum BioPharma Exits (1)

Quantum BioPharma’s most recent exit was on 19-Jul-2018 from Cannara Biotech. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Cannara Biotech 19-Jul-2018 Completed
To view Quantum BioPharma’s complete exits history, request access »

Quantum BioPharma Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Lucid Psycheceuticals Toronto, Canada 2020
FSD Atlantic Pharma St. John's, Canada 2018

Quantum BioPharma FAQs

  • When was Quantum BioPharma founded?

    Quantum BioPharma was founded in 1994.

  • Where is Quantum BioPharma headquartered?

    Quantum BioPharma is headquartered in Toronto, Canada.

  • What is the size of Quantum BioPharma?

    Quantum BioPharma has 7 total employees.

  • What industry is Quantum BioPharma in?

    Quantum BioPharma’s primary industry is Drug Discovery.

  • Is Quantum BioPharma a private or public company?

    Quantum BioPharma is a Public company.

  • What is Quantum BioPharma’s stock symbol?

    The ticker symbol for Quantum BioPharma is QNTM.

  • What is the current stock price of Quantum BioPharma?

    As of 20-Nov-2026 the stock price of Quantum BioPharma is $1.28.

  • What is the current market cap of Quantum BioPharma?

    The current market capitalization of Quantum BioPharma is $11.1M.

  • Who are Quantum BioPharma’s competitors?

    Avicanna and Tetra Bio-Pharma are competitors of Quantum BioPharma.

  • What is Quantum BioPharma’s annual earnings per share (EPS)?

    Quantum BioPharma’s EPS for 12 months was -$3.19.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process